PBMs Eye Acquisitions In “Target-Rich Environment”
Executive Summary
Medco could seek to grow through acquisitions that cost less than $300 mil
You may also be interested in...
Zocor, Zoloft And Pravachol Will Be Key Generic Switches For Medco In ’06
Medco sees a significant opportunity for growth in 2006 generic switches, Group President-National Accounts Timothy Wentworth says
Zocor, Zoloft And Pravachol Will Be Key Generic Switches For Medco In ’06
Medco sees a significant opportunity for growth in 2006 generic switches, Group President-National Accounts Timothy Wentworth says
Medco Says It Is Ready For Part D: Will CMS Be?
Medco is "leaning" toward participating directly in the Medicare Part D stand-alone prescription drug insurance program in 2006, CEO David Snow said during an analyst meeting Nov. 11 in Philadelphia